About: The natural history of multiple sclerosis: a geographically based study 9: Observations on the progressive phase of the disease

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: The natural history of multiple sclerosis: a geographically based study 9: Observations on the progressive phase of the disease Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

scientific article published on 09 January 2006

Attributes	Values
rdf:type	Item
description	wetenschappelijk artikel (nl) article scientifique publié en 2006 (fr) наукова стаття, опублікована в січні 2006 (uk) im Januar 2006 veröffentlichter wissenschaftlicher Artikel (de) artículu científicu espublizáu en xineru de 2006 (ast) scientific article published on 09 January 2006 (en)
publication date	wds:Q57912352-07F7FFE8-EB7C-414C-B3C4-C5BD7D9252BF
publication date	2006-01-09 00:00:00Z (xsd:dateTime)
language of work or name	wds:Q57912352-CB4DD027-3896-463D-8ABF-7377CD72DC9C
language of work or name	English
cites work	wds:Q57912352-0121A197-2412-420A-9563-4DA6F410F663 wds:Q57912352-04FB0189-19CB-4737-9789-F8CE89FCCB90 wds:Q57912352-0CB46CBD-6C0C-43C1-994D-E451759AA717 wds:Q57912352-1327897E-3067-4DC5-8CD6-FD9406A66F9F wds:Q57912352-1678D698-09B9-4807-A199-ADBA0B7CD5E4 wds:Q57912352-236D61E4-6036-452D-B275-97E60685BC06 wds:Q57912352-260D0E06-3043-40AA-A582-FCB2241A4729 wds:Q57912352-27E5186D-5CA2-47B3-A34D-A5BD692905B9 wds:Q57912352-2ACAFA1B-B21B-4BC1-8891-ABDAE642CF72 wds:Q57912352-32B16967-DEE7-403A-A7F7-6DE10432F5AE wds:Q57912352-45EDF975-E435-4A41-BB98-791767A76EBF wds:Q57912352-4CA69FBB-FEE3-4CA5-A480-BF0D44F54857 wds:Q57912352-4CF7021D-5EFC-4592-9A57-82AAD239D0CF wds:Q57912352-5BF66657-D22F-4092-9814-16225BE92F4E wds:Q57912352-5E263184-7567-4F06-B2B7-308742DECEE1 wds:Q57912352-6DE0A44B-631F-41E5-A113-8A7FDC15DF82 wds:Q57912352-71BE253C-4041-4479-A398-791F31A114B8 wds:Q57912352-75711275-9EE7-4C65-A33B-B707BFECFA8E wds:Q57912352-78F7F770-DEBA-4258-B472-0591CD3DFDA6 wds:Q57912352-82478826-D1E2-4F83-886D-027D7E0D7A4E wds:Q57912352-82F26111-F51D-4FB0-BAE0-225ED15692FD wds:Q57912352-98747BD5-D642-450D-9020-731AFA74CCC2 wds:Q57912352-A09D502C-6741-4FE7-92FF-9376185D640C wds:Q57912352-A4C9FABD-BA18-4A9A-81E3-98479BCEB0C8 wds:Q57912352-CBA2B2E3-ACFD-4AA2-9F86-B0B2CC2332A4 wds:Q57912352-D44D1868-8FB2-43B8-AE05-745C4F5D52D2 wds:Q57912352-D8E5D46E-8CEE-4930-AA3A-0C932D5D084B wds:Q57912352-DC0717B7-D198-4119-8122-2E2508844F0D wds:Q57912352-DE1322CD-A5DA-4114-A825-1179EF2B833D wds:Q57912352-E2912315-D537-4E68-BF5A-043262D4E4E0 wds:Q57912352-EBF986F6-B9C4-467D-B61A-96BA4B26F444 wds:Q57912352-F0083A74-E813-4D15-BE74-040123E540A4 wds:Q57912352-F49AE69F-126E-40A3-81A1-66D34E6736CE wds:Q57912352-F7923660-B7E5-497A-8D43-FFB36F4DFF12 wds:Q57912352-F92CE912-01AC-42C1-B1AF-78E012243568 wds:Q57912352-FF295C52-4029-443E-A763-4F8A7CC760BD
cites work	The clinical course of neuromyelitis optica (Devic's syndrome). New diagnostic criteria for multiple sclerosis: guidelines for research protocols Cladribine and progressive MS: Clinical and MRI outcomes of a multicenter controlled trial PROBLEMS OF EXPERIMENTAL TRIALS OF THERAPY IN MULTIPLE SCLEROSIS: REPORT BY THE PANEL ON THE EVALUATION OF EXPERIMENTAL TRIALS OF THERAPY IN MULTIPLE SCLEROSIS Copolymer 1 reduces relapse rate and improves disability in relapsing-remitting multiple sclerosis: results of a phase III multicenter, double-blind placebo-controlled trial. The Copolymer 1 Multiple Sclerosis Study Group Intramuscular interferon beta-1a for disease progression in relapsing multiple sclerosis. The Multiple Sclerosis Collaborative Research Group (MSCRG) Randomised double-blind placebo-controlled study of interferon β-1a in relapsing/remitting multiple sclerosis Axonal transection in the lesions of multiple sclerosis Axonal damage in acute multiple sclerosis lesions. Defining the clinical course of multiple sclerosis: Results of an international survey Rating neurologic impairment in multiple sclerosis: An expanded disability status scale (EDSS) The Mayo Clinic-Canadian Cooperative trial of sulfasalazine in active multiple sclerosis. Benign multiple sclerosis? Clinical course, long term follow up, and assessment of prognostic factors Early clinical predictors and progression of irreversible disability in multiple sclerosis: an amnesic process. Monoclonal antibody treatment exposes three mechanisms underlying the clinical course of multiple sclerosis Preliminary evidence from magnetic resonance imaging for reduction in disease activity after lymphocyte depletion in multiple sclerosis. The natural history of multiple sclerosis: a geographically based study. I. Clinical course and disability Multiple sclerosis that is progressive from the time of onset: clinical characteristics and progression of disability The natural history of multiple sclerosis: a geographically based study. 4. Applications to planning and interpretation of clinical therapeutic trials The natural history of multiple sclerosis: a geographically based study. 5. The clinical features and natural history of primary progressive multiple sclerosis The natural history of multiple sclerosis: a geographically based study. 6. Applications to planning and interpretation of clinical therapeutic trials in primary progressive multiple sclerosis. Prognostic factors in a multiple sclerosis incidence cohort with twenty-five years of follow-up. Primary progressive multiple sclerosis Behçet's disease and the nervous system Course and prognosis of multiple sclerosis assessed by the computerized data processing of 349 patients Clinical factors associated with increased disability in multiple sclerosis Open controlled therapeutic trial of intravenous immune globulin in relapsing-remitting multiple sclerosis The natural history of multiple sclerosis: a geographically based study. 3. Multivariate analysis of predictive factors and models of outcome. Course of multiple sclerosis. First results of a prospective study carried out of 102 MS patients from 1976-1980. Chronic systemic high-dose recombinant interferon alfa-2a reduces exacerbation rate, MRI signs of disease activity, and lymphocyte interferon gamma production in relapsing-remitting multiple sclerosis. A referendum on clinical trial research in multiple sclerosis: the opinion of the participants at the Jekyll Island workshop Disability outcome measures in therapeutic trials of relapsing-remitting multiple sclerosis: effects of heterogeneity of disease course in placebo cohorts Epidemiology of multiple sclerosis in London and Middlesex County, Ontario, Canada The natural history of multiple sclerosis: a geographically based study. 7. Progressive-relapsing and relapsing-progressive multiple sclerosis: a re-evaluation. A phase II trial of anti-CD4 antibodies in the treatment of multiple sclerosis. Clinical parameters and intrathecal IgG synthesis as prognostic features in multiple sclerosis. Part I
author name string	wds:Q57912352-0A611AE3-5895-4A17-B7F1-7A6091507AA1 wds:Q57912352-4511A4D9-A5EF-469C-876A-EE7244DAEB56 wds:Q57912352-C2D6E078-4326-4925-B0EB-B16C739D7E70 wds:Q57912352-DBC8633F-DBF5-4C7E-A54B-FC970F481C08
author name string	Kremenchutzky M Wingerchuk DM Rice GP Baskerville J
rdfs:label	The natural history of multiple sclerosis: a geographically based study 9: Observations on the progressive phase of the disease (en) The natural history of multiple sclerosis: a geographically based study 9: Observations on the progressive phase of the disease (nl)
skos:prefLabel	The natural history of multiple sclerosis: a geographically based study 9: Observations on the progressive phase of the disease (en) The natural history of multiple sclerosis: a geographically based study 9: Observations on the progressive phase of the disease (nl)
name	The natural history of multiple sclerosis: a geographically based study 9: Observations on the progressive phase of the disease (en) The natural history of multiple sclerosis: a geographically based study 9: Observations on the progressive phase of the disease (nl)
author	wds:Q57912352-C0CC30B0-F026-4767-A067-4C2C2BB1EE25
author	George C. Ebers
title	wds:Q57912352-D4C6E768-93F2-44EB-B99C-5FBDC8431D5E

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 172 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software